NERM
ILMN icon

New England Research & Management’s Illumina ILMN Stock Holding History

New England Research & Management’s Portfolio ILMN Stock Details ILMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-656
Closed -$223K – 167
2022
Q1 		$223K Sell
656
-29
-4% -$9.79K 0.12% 149
2021
Q4 		$253K Sell
685
-1,577
-70% -$598K 0.12% 161
2021
Q3 		$892K Buy
+2,262
New +$1.04M 0.47% 75

Other funds holding ILMN

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

New England Research & Management's ILMN Position: Q2 2022 in Review

New England Research & Management sold out of Illumina (ILMN) in Q2 2022, closing a stake of 656 shares — an estimated $223K sold.

New England Research & Management first reported a position in ILMN in Q3 2021 and held it in 3 quarters. The position peaked at $892K in Q3 2021. 911 funds tracked by Wall St. Rank hold ILMN as of Q2 2022.

  • New England Research & Management reported no remaining Illumina position as of Q2 2022 after selling out during the quarter.
  • New England Research & Management sold 656 Illumina shares in Q2 2022, an estimated $223K.
  • New England Research & Management first reported a position in Illumina in Q3 2021 and held it in 3 quarters.
  • New England Research & Management's Illumina position peaked at $892K in Q3 2021.
  • 911 funds tracked by Wall St. Rank held Illumina as of Q2 2022.

Based on New England Research & Management's 13F filing for Q2 2022, filed 20 Jul 2022.